Triskel Integrated Services is a leading pharmaceutical regulatory consulting and product development support brand with a strong presence in Europe and the United States. With over 25 years of experience, Triskel has assisted more than 130 biotech and pharma companies in their strategic consulting needs. Their expertise spans across various areas, including recombinant proteins, mAbs, peptides, vaccines, extracted biologics, and cell-based medicinal products, resulting in an impressive track record of over 35 Marketing Authorisations.

Triskel has been recognized for its exceptional work in the industry, receiving nominations for the TOPRA award for regulatory excellence in 2013 and being honored with the TOPRA prize. In addition, they received a badge of honor from IFAH in 2019. With a focus on successful drug development plans, optimal regulatory strategies, and marketing authorizations, Triskel has consistently achieved groundbreaking results in their projects.

They have provided CMC/Quality development plans for 40 medicinal products, full development plans for 16 products, and conducted 39 due diligence cases. Their expertise also extends to toxicology, pharmacology, clinical reviews, protocol design, and preparation of ICH clinical study reports. Based in Geneva, Switzerland, Triskel Integrated Services is an independent CMC and regulatory affairs consultancy trusted by numerous clients worldwide.

Contact them today to benefit from their comprehensive services and industry-leading expertise